New York Ozempic Stomach Paralysis Lawsuit (2024 Update)

Quick Summary

• In New York, Ozempic users are filing lawsuits alleging that the drug caused stomach paralysis, a condition known as gastroparesis.
• This article provides updates on the New York Ozempic stomach paralysis lawsuit, details the case against Novo Nordisk, and outlines the steps for potentially affected individuals to take legal action.
• If you or someone you know has been affected by complications from Ozempic, Schmidt & Clark, LLP, is here to assist you. Renowned for our proficiency in plaintiff representation, our main objective is to ensure you obtain the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by offering a free confidential case evaluation. Navigating pharmaceutical litigation can be complex, but you don’t have to do it alone.

Our law firm offers nationwide legal representation, extending our services to individual litigation across all 50 states. No matter your location, you are guaranteed the support you need in these challenging times.

We can help you in the following ways:

• Providing expert legal advice and representation.
• Assisting with the collection and organization of necessary documentation.
• Guiding you through the entire legal process from start to finish.

Ozempic Stomach Paralysis Lawsuit

The legal landscape is filled with Ozempic stomach paralysis lawsuits, with New York being a significant hub for this litigation.

The Ozempic lawsuit primarily alleges that Novo Nordisk did not sufficiently inform patients and healthcare providers about the drug’s potential to cause severe gastrointestinal events.

Plaintiffs claim that with adequate information, they might have avoided the severe vomiting and stomach pain associated with gastroparesis, a condition that causes delayed stomach emptying and severe gastrointestinal issues. This alleged oversight has reportedly led to stomach paralysis and other complications for patients.

Additionally, the company’s marketing practices are being scrutinized for potentially misrepresenting the safety profile of Ozempic and downplaying serious risks, which left consumers unaware of possible severe health complications.

With an increasing number of individuals seeking compensation for these health issues, the Ozempic lawsuit presents a notable challenge to the drug manufacturer’s duty to inform its consumers.

What Is Ozempic?

According to Healthline, Ozempic is a medication known generically as semaglutide. It entered the pharmaceutical market with FDA approval in 2017 as a treatment for adults with type 2 diabetes [1].

As one of the diabetes drugs, it works by mimicking a hormone that signals the brain to feel full and slowing digestion, effectively lowering blood sugar levels in patients.

Although not officially approved for weight loss, the influence of Ozempic on weight reduction has led to off-label prescriptions and its inclusion in higher doses in another weight management drug, Wegovy.

Ozempic’s ability to extend the time food takes to exit the body, a condition called delayed gastric emptying, is a double-edged sword. This effect, which delays gastric emptying, offers therapeutic benefits while also raising concerns about its link to gastroparesis.

In the world of medical advancements, Ozempic and Mounjaro represent two distinct entities that contribute to the understanding of gastric emptying.

Was Ozempic Recalled?

Ozempic was not recalled, but the FDA’s involvement with the drug has intensified as its side effects have come to light. A warning was added to the Ozempic label regarding an increased risk of ileus, an obstruction that prevents food or liquid from passing through the colon.

While there hasn’t been an official recall, the added warnings and ongoing FDA meta-analysis of clinical trials and postmarketing data reflect growing concerns over the safety profile of semaglutide-containing medications.

For those suffering symptoms like abdominal pain, nausea, or vomiting, the FDA advises healthcare professionals to monitor closely and consider discontinuing Ozempic if an ileus is suspected.

Side Effects of Ozempic

Examining the medical basis of the Ozempic lawsuit, we find gastroparesis – a condition where the stomach muscles slow down or halt the movement of food through the digestive system.

This can lead to a slew of distressing symptoms like:

• Nausea
• Vomiting
• Abdominal pain
• Dehydration

These symptoms, often related to severe stomach problems, severely impact a person’s quality of life. Medications like Ozempic have been linked to this condition because they delay gastric emptying, potentially leading to stomach paralysis and a harrowing condition known as cyclic vomiting syndrome.

It’s a condition that’s not only difficult to manage but also complex to diagnose, often requiring a meticulous process of elimination to pinpoint the cause.

According to a 2023 research by NIH, the connection between Ozempic and gastroparesis has become a focal point for legal action, as seen in research published by reputable medical journals that flag a heightened risk of gastrointestinal complications from GLP-1 agonists like Ozempic [2].

Who Should Not Use Ozempic?

Individuals with a personal or family history of medullary thyroid carcinoma, and those with a history of pancreatitis, kidney problems, or allergic reactions to its ingredients should not use Ozempic.

Women who are pregnant or planning to conceive should discontinue use at least two months in advance, given the uncertainty of Ozempic’s safety during pregnancy.

Furthermore, interactions with other medications and alcohol can affect Ozempic’s efficacy and should be considered when assessing its suitability.

New research links weight loss medications like Ozempic and Wegovy to a greater risk of pancreatitis, gastroparesis, and bowel obstruction – Mohit Sodhi, MSc, Research at The Faculty of Medicine, University of British Columbia, Canada

How Do You Qualify for an Ozempic Stomach Paralysis Lawsuit?

To qualify for an Ozempic stomach paralysis lawsuit, you must have been prescribed and taken Ozempic, Rybelsus, or Wegovy, developed a related diagnosis such as gastroparesis, and sought medical care for the condition.

The evidence to support your claim must include medical documentation of the prescription, a corresponding diagnosis, and proof of financial losses due to the adverse health condition.

However, there are navigational buoys to heed; certain exclusions may affect eligibility, such as undergoing cancer treatment, having certain gastric surgeries, or missing the statute of limitations, all of which can impact patient safety.

The Status Of The Ozempic Lawsuit Litigation in New York

In New York, the Ozempic lawsuit litigation is progressing through the legal system. Cases from across the country are being transferred to a federal Multidistrict Litigation (MDL) for pretrial proceedings, a process designed to improve efficiency and reduce costs.

This consolidation, known as MDL 3094, aims to streamline the handling of these numerous cases, all sharing similar legal questions about the link between Ozempic and stomach paralysis.

The advantage of an MDL lies in the pooling of resources for plaintiffs and the avoidance of repetitive legal procedures for defendants, leading to more consistent rulings across lawsuits.

The timeline for Ozempic litigation includes several notable events:

• The first lawsuit was filed on August 2, 2023.
• The number of lawsuits has continued to grow, with over 100 cases pending in the MDL as of May 2024.
• Key moments, such as the ‘Science Day’ and the initial status conference, provide insights into the medical and scientific aspects of the cases.

These milestones mark the progression of the legal journey surrounding Ozempic.

However, the unexpected passing of the initial federal judge overseeing the MDL has introduced a variable that could influence the trajectory of these lawsuits.

Ozempic Lawsuit Settlement Amounts in New York

As the Ozempic lawsuits navigate toward potential settlements, the amounts in question are not set in stone but depend on the individual damages claimed.

For those with extensive losses related to gallbladder injuries, settlements in New York could range from $400,000 to $700,000, offering a ray of financial relief amidst the storm.

Filing an Ozempic Stomach Paralysis Lawsuit in New York

To begin the process of filing an Ozempic lawsuit in New York, you will need to follow a series of steps, starting with an initial consultation and possibly moving towards negotiating a settlement or preparing for trial.

Legal Strategies and Challenges

Dealing with the legal intricacies of an Ozempic lawsuit demands strategic planning and a clear grasp of potential challenges. Proving the direct link between Ozempic and stomach paralysis is a formidable task, requiring a robust compilation of medical records and expert testimony.

Disputes among plaintiff lawyers over leadership positions and differing opinions on how to determine causation have introduced additional obstacles in the Ozempic litigation.

Types of Evidence To Present

To build a strong case, plaintiffs must present a variety of evidence, including:

• Hospital records
• Doctor’s notes
• Medical bills

Anything that chronicles the journey from Ozempic prescription to health complications is crucial. Additionally, expert testimonies, alongside clinical trials and observational studies, can help establish a connection between Ozempic and gastrointestinal injuries.

What is the Statute of Limitations for an Ozempic Lawsuit in New York?

The statute of limitations for an Ozempic lawsuit in New York is generally three years from the date of injury for product liability cases. However, in the case of wrongful death, the window narrows to two years, underscoring the urgency for affected individuals to act swiftly.

Related Articles:

• Georgia Ozempic Stomach Paralysis Lawsuit
• Texas Ozempic Stomach Paralysis Lawsuit
• Michigan Ozempic Stomach Paralysis Lawsuit

See all related dangerous drug lawsuits our attorneys covered so far.

Get Your Free Consultation From Our New York Ozempic Lawyers

The Schmidt & Clark, LLP law firm stands ready to assist you during these challenging times. If you or a loved one has experienced complications from weight loss drugs like Ozempic, reach out to us without delay.

Our team possesses extensive expertise in managing such cases and will navigate you through the legal process. We will clarify your rights and determine your eligibility for a lawsuit concerning these complications.

Benefit from a free case evaluation, and remember, we only collect fees if we win your case. You can trust that our dedication to your case is as unwavering as if you were part of our own family. Contact us today for a thorough review of your situation.

Reference:

1. https://www.healthline.com/health/drugs/ozempic
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874596/